Training on Pfizer‒BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran) - Updated 5 October 2021

Language
Published
2021

This is a training resource for Tozinameran COVID-19 mRNA Vaccine (nucleoside modified) ‒ COMIRNATY® (Pfizer‒BioNTech) that: 1. describes what is new and different for introducing Tozinameran COVID-19 mRNA vaccine (Pfizer–BioNTech); and 2. identifies key programmatic considerations involved in introducing this vaccine.